Back

Proprotein convertase subtilisin/kexin type 9 (PCSK9) plasma levels are associated with the metabolic syndrome in patients with stable coronary artery disease

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Lipids Lipids ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Chiara Caselli

CNR – National Research Council, Pisa (Italy)

14 More presentations in this session

Presentation thumbnail
Doctor C. Rodriguez (The Bronx, US)
Abstract
Presentation thumbnail
Professor G. Schwartz (Aurora, US)
Abstract
Presentation thumbnail
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Doctor M. Santos (Funchal, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 7 - Lipids

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
Risk assessment and lipid management in primary prevention
thumbnail
Congress Presentation
State-of-the-art lecture on how to keep your arteries young by tackling dyslipidaemia

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources